CN1724686A - 用于检测肺炎支原体的靶序列和试剂盒 - Google Patents
用于检测肺炎支原体的靶序列和试剂盒 Download PDFInfo
- Publication number
- CN1724686A CN1724686A CN 200410052942 CN200410052942A CN1724686A CN 1724686 A CN1724686 A CN 1724686A CN 200410052942 CN200410052942 CN 200410052942 CN 200410052942 A CN200410052942 A CN 200410052942A CN 1724686 A CN1724686 A CN 1724686A
- Authority
- CN
- China
- Prior art keywords
- mycoplasma pneumoniae
- primer
- seq
- sequence
- mycoplasma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 241000204031 Mycoplasma Species 0.000 title claims description 5
- 239000003153 chemical reaction reagent Substances 0.000 title 1
- 241000202934 Mycoplasma pneumoniae Species 0.000 claims abstract description 88
- 239000000523 sample Substances 0.000 claims abstract description 49
- 238000000034 method Methods 0.000 claims abstract description 28
- 238000012360 testing method Methods 0.000 claims abstract description 28
- 239000002773 nucleotide Substances 0.000 claims abstract description 20
- 125000003729 nucleotide group Chemical group 0.000 claims abstract description 20
- 230000002068 genetic effect Effects 0.000 claims abstract description 17
- 239000003550 marker Substances 0.000 claims abstract description 17
- 108090000623 proteins and genes Proteins 0.000 claims description 33
- 238000001514 detection method Methods 0.000 claims description 29
- 230000021164 cell adhesion Effects 0.000 claims description 21
- 230000003321 amplification Effects 0.000 claims description 14
- 238000006243 chemical reaction Methods 0.000 claims description 14
- 238000004519 manufacturing process Methods 0.000 claims description 14
- 238000003199 nucleic acid amplification method Methods 0.000 claims description 14
- 239000007788 liquid Substances 0.000 claims description 10
- 238000003776 cleavage reaction Methods 0.000 claims description 8
- 230000007017 scission Effects 0.000 claims description 8
- 239000013558 reference substance Substances 0.000 claims description 7
- 238000012408 PCR amplification Methods 0.000 claims description 4
- 239000013642 negative control Substances 0.000 claims description 4
- 230000000295 complement effect Effects 0.000 claims description 3
- 241000204003 Mycoplasmatales Species 0.000 abstract description 10
- 108020004414 DNA Proteins 0.000 description 35
- 238000003752 polymerase chain reaction Methods 0.000 description 33
- 239000007850 fluorescent dye Substances 0.000 description 12
- 239000000243 solution Substances 0.000 description 12
- 208000001572 Mycoplasma Pneumonia Diseases 0.000 description 10
- 241000204051 Mycoplasma genitalium Species 0.000 description 10
- 201000008235 Mycoplasma pneumoniae pneumonia Diseases 0.000 description 8
- 239000000047 product Substances 0.000 description 7
- 238000009004 PCR Kit Methods 0.000 description 6
- 230000001717 pathogenic effect Effects 0.000 description 6
- 102000004169 proteins and genes Human genes 0.000 description 6
- 108020004465 16S ribosomal RNA Proteins 0.000 description 5
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 5
- 238000004458 analytical method Methods 0.000 description 5
- 239000012634 fragment Substances 0.000 description 5
- 102000004190 Enzymes Human genes 0.000 description 4
- 108090000790 Enzymes Proteins 0.000 description 4
- 241000282414 Homo sapiens Species 0.000 description 4
- 108010034608 Mycoplasma pneumoniae adhesin Proteins 0.000 description 4
- 238000000137 annealing Methods 0.000 description 4
- 230000003416 augmentation Effects 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 238000013461 design Methods 0.000 description 4
- 239000012154 double-distilled water Substances 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 238000002866 fluorescence resonance energy transfer Methods 0.000 description 4
- 208000015181 infectious disease Diseases 0.000 description 4
- 108020004707 nucleic acids Proteins 0.000 description 4
- 102000039446 nucleic acids Human genes 0.000 description 4
- 150000007523 nucleic acids Chemical class 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 238000010791 quenching Methods 0.000 description 4
- 230000000171 quenching effect Effects 0.000 description 4
- ABZLKHKQJHEPAX-UHFFFAOYSA-N tetramethylrhodamine Chemical compound C=12C=CC(N(C)C)=CC2=[O+]C2=CC(N(C)C)=CC=C2C=1C1=CC=CC=C1C([O-])=O ABZLKHKQJHEPAX-UHFFFAOYSA-N 0.000 description 4
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 3
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 3
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 230000000968 intestinal effect Effects 0.000 description 3
- 238000011002 quantification Methods 0.000 description 3
- 238000003753 real-time PCR Methods 0.000 description 3
- 125000006853 reporter group Chemical group 0.000 description 3
- 230000035945 sensitivity Effects 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- 208000030507 AIDS Diseases 0.000 description 2
- 241001647372 Chlamydia pneumoniae Species 0.000 description 2
- 241001647378 Chlamydia psittaci Species 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- 241000191967 Staphylococcus aureus Species 0.000 description 2
- 229930003756 Vitamin B7 Natural products 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 239000000969 carrier Substances 0.000 description 2
- 239000012295 chemical reaction liquid Substances 0.000 description 2
- 238000012136 culture method Methods 0.000 description 2
- 230000009089 cytolysis Effects 0.000 description 2
- 238000013016 damping Methods 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 210000000265 leukocyte Anatomy 0.000 description 2
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Natural products C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 2
- -1 methane amide Chemical class 0.000 description 2
- 239000013612 plasmid Substances 0.000 description 2
- 238000004321 preservation Methods 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 230000009466 transformation Effects 0.000 description 2
- GPRLSGONYQIRFK-MNYXATJNSA-N triton Chemical compound [3H+] GPRLSGONYQIRFK-MNYXATJNSA-N 0.000 description 2
- 239000011735 vitamin B7 Substances 0.000 description 2
- 235000011912 vitamin B7 Nutrition 0.000 description 2
- WCKQPPQRFNHPRJ-UHFFFAOYSA-N 4-[[4-(dimethylamino)phenyl]diazenyl]benzoic acid Chemical compound C1=CC(N(C)C)=CC=C1N=NC1=CC=C(C(O)=O)C=C1 WCKQPPQRFNHPRJ-UHFFFAOYSA-N 0.000 description 1
- BZTDTCNHAFUJOG-UHFFFAOYSA-N 6-carboxyfluorescein Chemical compound C12=CC=C(O)C=C2OC2=CC(O)=CC=C2C11OC(=O)C2=CC=C(C(=O)O)C=C21 BZTDTCNHAFUJOG-UHFFFAOYSA-N 0.000 description 1
- FRXSZNDVFUDTIR-UHFFFAOYSA-N 6-methoxy-1,2,3,4-tetrahydroquinoline Chemical compound N1CCCC2=CC(OC)=CC=C21 FRXSZNDVFUDTIR-UHFFFAOYSA-N 0.000 description 1
- 108091026890 Coding region Proteins 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 238000007400 DNA extraction Methods 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 241001430197 Mollicutes Species 0.000 description 1
- 238000002944 PCR assay Methods 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 101710172711 Structural protein Proteins 0.000 description 1
- 108060008682 Tumor Necrosis Factor Proteins 0.000 description 1
- 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000005875 antibody response Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000005336 cracking Methods 0.000 description 1
- 230000037029 cross reaction Effects 0.000 description 1
- 230000001186 cumulative effect Effects 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 1
- 230000014509 gene expression Effects 0.000 description 1
- 208000002672 hepatitis B Diseases 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- 230000009456 molecular mechanism Effects 0.000 description 1
- 239000002547 new drug Substances 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000012913 prioritisation Methods 0.000 description 1
- 230000002685 pulmonary effect Effects 0.000 description 1
- 238000004451 qualitative analysis Methods 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 239000013074 reference sample Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 238000010189 synthetic method Methods 0.000 description 1
- 201000008827 tuberculosis Diseases 0.000 description 1
- 229960005486 vaccine Drugs 0.000 description 1
- 238000003805 vibration mixing Methods 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
待测样本 | Ct值 | 病毒量(拷贝数/ul) |
1 | 20.76 | 1.28×106 |
2 | 31.04 | 3.83×102 |
3 | 26.55 | 1.32×104 |
4 | 37.69 | 2.00×100 |
5 | 21.56 | 6.85×105 |
6 | 20.90 | 1.15×106 |
7 | 27.57 | 5.95×103 |
8 | 31.68 | 2.31×102 |
模板来源 | Ct值 |
生殖支原体 | - |
肺炎衣原体 | - |
鹦鹉热衣原体 | - |
人形支原体 | - |
金黄色葡萄球菌 | - |
人白细胞DNA | - |
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 200410052942 CN1724686B (zh) | 2004-07-19 | 2004-07-19 | 用于检测肺炎支原体的靶序列和试剂盒 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 200410052942 CN1724686B (zh) | 2004-07-19 | 2004-07-19 | 用于检测肺炎支原体的靶序列和试剂盒 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1724686A true CN1724686A (zh) | 2006-01-25 |
CN1724686B CN1724686B (zh) | 2010-06-23 |
Family
ID=35924317
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 200410052942 Expired - Lifetime CN1724686B (zh) | 2004-07-19 | 2004-07-19 | 用于检测肺炎支原体的靶序列和试剂盒 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1724686B (zh) |
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101545010A (zh) * | 2009-05-11 | 2009-09-30 | 北京海康基因芯片开发有限公司 | 一种检测传染病病原体的方法及试剂盒 |
CN102230013A (zh) * | 2011-06-21 | 2011-11-02 | 中国疾病预防控制中心传染病预防控制所 | 检测肺炎支原体的靶序列、引物和探针及其试剂盒 |
CN101665826B (zh) * | 2009-05-06 | 2012-03-07 | 珠海市银科医学工程有限公司 | 用于环介导恒温扩增技术检测临床肺炎支原体的引物 |
CN103060451A (zh) * | 2013-01-10 | 2013-04-24 | 湖南圣湘生物科技有限公司 | 一种肺炎支原体mp检测试剂盒 |
CN103993102A (zh) * | 2014-03-07 | 2014-08-20 | 崔淑娟 | 一种同时检测人腺病毒、人肺炎支原体、人博卡病毒的方法及试剂盒 |
CN104109721A (zh) * | 2014-03-07 | 2014-10-22 | 崔淑娟 | 一种同时检测rna病毒、dna病毒、支原体和衣原体的方法 |
CN105238860A (zh) * | 2015-10-15 | 2016-01-13 | 中国人民解放军疾病预防控制所 | 用于检测肺炎支原体的lamp试剂盒及其专用引物 |
CN106399542A (zh) * | 2016-10-26 | 2017-02-15 | 沈阳优宁生物科技有限公司 | 一种肺炎支原体的滚环恒温扩增快速检测引物及试剂盒 |
CN108411037A (zh) * | 2018-03-26 | 2018-08-17 | 郑州安图生物工程股份有限公司 | 一种能同时区分三种病原体核酸的冻干试剂 |
CN111621582A (zh) * | 2020-07-29 | 2020-09-04 | 圣湘生物科技股份有限公司 | 检测肺炎支原体的组合物、试剂盒、用途及其方法 |
CN114107529A (zh) * | 2021-12-13 | 2022-03-01 | 北京华诺奥美基因医学检验实验室有限公司 | 一种肺炎支原体核酸检测试剂盒 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU6128900A (en) * | 1999-09-29 | 2001-04-05 | Pfizer Products Inc. | Nucleic acids and proteins of the mycoplasma hyopneumoniae mph3 gene and uses thereof |
-
2004
- 2004-07-19 CN CN 200410052942 patent/CN1724686B/zh not_active Expired - Lifetime
Cited By (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101665826B (zh) * | 2009-05-06 | 2012-03-07 | 珠海市银科医学工程有限公司 | 用于环介导恒温扩增技术检测临床肺炎支原体的引物 |
CN101545010A (zh) * | 2009-05-11 | 2009-09-30 | 北京海康基因芯片开发有限公司 | 一种检测传染病病原体的方法及试剂盒 |
CN101545010B (zh) * | 2009-05-11 | 2014-07-16 | 海康生命科技有限公司 | 一种检测传染病病原体的方法及试剂盒 |
CN102230013A (zh) * | 2011-06-21 | 2011-11-02 | 中国疾病预防控制中心传染病预防控制所 | 检测肺炎支原体的靶序列、引物和探针及其试剂盒 |
CN103060451A (zh) * | 2013-01-10 | 2013-04-24 | 湖南圣湘生物科技有限公司 | 一种肺炎支原体mp检测试剂盒 |
CN103060451B (zh) * | 2013-01-10 | 2016-03-02 | 湖南圣湘生物科技有限公司 | 一种肺炎支原体mp检测试剂盒 |
CN104109721A (zh) * | 2014-03-07 | 2014-10-22 | 崔淑娟 | 一种同时检测rna病毒、dna病毒、支原体和衣原体的方法 |
CN103993102A (zh) * | 2014-03-07 | 2014-08-20 | 崔淑娟 | 一种同时检测人腺病毒、人肺炎支原体、人博卡病毒的方法及试剂盒 |
CN105238860A (zh) * | 2015-10-15 | 2016-01-13 | 中国人民解放军疾病预防控制所 | 用于检测肺炎支原体的lamp试剂盒及其专用引物 |
CN106399542A (zh) * | 2016-10-26 | 2017-02-15 | 沈阳优宁生物科技有限公司 | 一种肺炎支原体的滚环恒温扩增快速检测引物及试剂盒 |
CN108411037A (zh) * | 2018-03-26 | 2018-08-17 | 郑州安图生物工程股份有限公司 | 一种能同时区分三种病原体核酸的冻干试剂 |
CN111621582A (zh) * | 2020-07-29 | 2020-09-04 | 圣湘生物科技股份有限公司 | 检测肺炎支原体的组合物、试剂盒、用途及其方法 |
CN111621582B (zh) * | 2020-07-29 | 2020-10-30 | 圣湘生物科技股份有限公司 | 检测肺炎支原体的组合物、试剂盒、用途及其方法 |
CN114107529A (zh) * | 2021-12-13 | 2022-03-01 | 北京华诺奥美基因医学检验实验室有限公司 | 一种肺炎支原体核酸检测试剂盒 |
Also Published As
Publication number | Publication date |
---|---|
CN1724686B (zh) | 2010-06-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1167811C (zh) | 酶原性核酸的检测方法,以及相关分子和试剂盒 | |
CN1237186C (zh) | 有效检测丙型肝炎病毒(hcv)的寡核苷酸引物及其应用方法 | |
CN1940087A (zh) | 一种同步扩增检测肝炎及艾滋病毒核酸的方法及试剂盒 | |
CN1932041A (zh) | 对于赤鹿、梅花鹿、马鹿以及驯鹿的基因特异的引物以及利用该引物识别鹿茸品种的方法 | |
CN101038254A (zh) | 一种检测曲霉菌荧光定量pcr试剂盒 | |
CN1944673A (zh) | 乙型肝炎病毒荧光定量pcr检测方法及专用试剂盒 | |
CN1814805A (zh) | H5、h7、h9亚型禽流感病毒的实时荧光定量pcr检测方法 | |
CN1670221A (zh) | 用于禽流感h5、h7和h9亚型多重实时荧光rt-pcr检测的引物、探针序列和方法 | |
CN1724686A (zh) | 用于检测肺炎支原体的靶序列和试剂盒 | |
CN101045943A (zh) | 添有扩增内标的沙门氏菌pcr检测方法 | |
CN1930302A (zh) | 用于检测临床样品中的病原分枝杆菌的方法 | |
CN1582339A (zh) | 用基于转录的扩增来扩增和检测dna的方法 | |
CN1720335A (zh) | 病原生物的多种分析检测 | |
CN1940090A (zh) | 快速检测hiv病毒的核苷酸序列、方法及体外诊断试剂盒 | |
CN1269966C (zh) | 用基于转录的扩增来扩增和检测hbvdna的方法 | |
CN1274847C (zh) | 环庚基脂环酸菌的核酸引物及鉴定环庚基脂环酸菌的方法 | |
CN1188530C (zh) | Sars病毒的基因检测试剂盒及检测方法 | |
CN101045942A (zh) | 转基因番木瓜及其加工产品中转基因成分的检测 | |
CN1637152A (zh) | 用于检测副溶血弧菌的耐热性溶血素相关溶血素基因的检测试剂 | |
CN1763224A (zh) | 肠出血性大肠杆菌o157:h7菌株的检测方法 | |
CN1216894C (zh) | 利用发夹结构产生信号的核酸扩增及检测方法 | |
CN1834258A (zh) | 一种鉴定结核分支杆菌菌种的多重pcr的引物设计方法 | |
CN1243106C (zh) | Y染色体多色荧光复合扩增试剂盒 | |
CN1405320A (zh) | 人工序列模板引物集及用途 | |
CN1480538A (zh) | 转基因油菜籽及其加工产品中转基因成分的定量检测 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Free format text: FORMER OWNER: SHANGHAI FUXING MEDICAL TECHNOLOGY DEVELOPMENT CO., LTD. Owner name: SHANGHAI FUXING MEDICAL TECHNOLOGY DEVELOPMENT CO. Free format text: FORMER OWNER: SHANGHAI HUATAI BIOTECHNOLOGY INDUSTRY CO., LTD. Effective date: 20100415 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 200063 NO.663, NINGXIA ROAD, SHANGHAI CITY TO: 200233 NO.1289, YISHAN ROAD, SHANGHAI CITY |
|
TA01 | Transfer of patent application right |
Effective date of registration: 20100415 Address after: 200233 Yishan Road, Shanghai, No. 1289 Applicant after: Shanghai Fosun Pharmaceutical (Group) Co.,Ltd. Address before: 200063 No. 663, Ningxia Road, Shanghai Applicant before: SHANGHAI HUATAI BIOENGINEERING INDUSTRY Co.,Ltd. Co-applicant before: Shanghai Fosun Pharmaceutical (Group) Co.,Ltd. |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CP03 | Change of name, title or address |
Address after: 201315 Shanghai city Pudong New Area Kangshi Road No. 393 room 17 Patentee after: SHANGHAI XINGYAO MED-TECH DEVELOPMENT CO.,LTD. Address before: 200233 Yishan Road, Shanghai, No. 1289 Patentee before: Shanghai Fosun Pharmaceutical (Group) Co.,Ltd. |
|
CP03 | Change of name, title or address | ||
CX01 | Expiry of patent term | ||
CX01 | Expiry of patent term |
Granted publication date: 20100623 |